a b s t r a c t Acute infection in vitro microRNA mRNA Systematic profiling In order to investigate the global and dynamic host microRNAs (miRNAs)/messenger RNAs (mRNAs) expression alteration during in vitro acute HCV infection, a comprehensive microarray analysis was performed using human hepatoma cells. Totally, 108 human miRNAs and 1247 mRNAs were identified whose expression levels changed for more than 2.0-fold in response to HCV infection. Upon HCV infection, signature from the unique miRNA expression pattern reflected the involvement of miRNA-regulated host cellular physiology and antiviral mechanism, whereas a preponderance of differentially regulated genes associated with metabolism, cell growth, apoptosis and cytokine/chemokine pathways. Furthermore, a reverse regulatory association of differentially expressed miRNAs and their predicted targets was constructed. Finally, the differentially expressed miRNAs such as miR-24, miR-149⁎, miR-638 and miR-1181 were identified to be involved in HCV entry, replication and propagation. These results suggest that combined miRNA and mRNA profiling may have superior potential as a diagnostic and mechanistic feature in HCV infection.
Introduction
Hepatitis C virus (HCV) is a major human blood-borne pathogen that has infected almost 170 million people worldwide and induces hepatic cirrhosis and hepatocellular carcinomas (HCC) (Choo et al., 1989; Shepard et al., 2005) . Our understanding of the dynamic host response to HCV infection had been greatly hampered until the JFH-1derived cell culture-grown HCV (HCVcc) system became available in 2005 (Cai et al., 2005; Lindenbach et al., 2005; Wakita et al., 2005; Zhong et al., 2005) . This new HCVcc system now permits us to study the entire virus life cycle in vitro and to devise strategies for prophylactic and therapeutic interventions.
Up to date, JFH-1 or JFH-1-derived chimeras have been successfully utilized in studies such as co-receptor identification and virus transmission (Evans et al., 2007; Liu et al., 2009; Timpe et al., 2008) , immune and chemokine pathways (Johansson et al., 2007; Uzri and Gehrke, 2009; Ye et al., 2009) , fatty acid synthesis (Yang et al., 2008a) , rRNA transcription (Raychaudhuri et al., 2009) , lipid metabolism (Amemiya et al., 2008) and apoptosis (Zhu et al., 2007) . Increasing evidence has demonstrated that microRNAs (miRNAs) have profound impact in modulating HCV infection and host defense (Jopling et al., 2005; Pedersen et al., 2007) . Similar to small interference RNA (siRNA), miRNAs are small, endogenous non-coding RNAs that assemble into RISC complexes, guide them onto target transcripts and then bind mRNAs at their 3′ untranslated regions (UTR) and ultimately induce mRNA degradation or suppress protein translation (Bartel, 2004) . Many miRNAs are regulated in response to cellular stress including infections and are known to modify essential cellular functions of antiviral effects, cell proliferation, differentiation and apoptosis (Marsit et al., 2006) . For example, a recent study has implicated the liver-specific miR-122 as an essential regulator of HCV replication in cultured human hepatoma cell Huh7 (Jopling et al., 2005) . Moreover, another study of chronic hepatitis C liver biopsies demonstrated that the miR-122 level was markedly lower in primary nonresponding subjects than in early virological responding subjects regardless of the HCV genotype examined (Sarasin-Filipowicz et al., 2009 ). Furthermore, researchers recently discovered that interferon beta (IFNβ) rapidly modulated host miRNAs, of which five showed significant anti-HCV effects in a viral sequence-specific manner (Pedersen et al., 2007) . Above evidence suggests a critical role of host miRNAs in regulating HCV infection.
Although the miRNA expression profile was investigated recently in HCC to reveal the mechanisms of liver oncogenic progress (Varnholt et al., 2008) , the dynamic and global changes of miRNA expressions in HCVcc-infected cell culture model has yet to be extensively elucidated. In this study, we performed comprehensive miRNA and mRNA profilings using HCVcc-infected Huh7.5.1 cells. The roles of several identified miRNAs were subsequently examined for their capabilities to regulate HCV infection and replication.
Results

HCV infection alters host miRNA expression in hepatoma cells
To profile global changes in miRNAs, naïve Huh7.5.1 cells were inoculated with relative high titer (MOI = 1.0) JFH-1 virus or same amount of UV-inactivated virus (HCVUV) at day 0 for overnight and then washed and allowed for further culture for 1, 2, 3 and 4 days, respectively, before total RNA preparation. Virus infection at various time points was confirmed by immunofluorescent staining of the cells with antibody against HCV structure protein Core. The percentage of Core-positive cells increased gradually over the course of infection, while the HCVUV-infected cells showed completely negative staining at all times (Supplemental Fig. 1A) . To monitor the possible virus infection-caused cytotoxicity, the MTT assay was carried out. Upon inoculation of Huh7.5.1 cells with HCV or HCVUV, no significant cell death was observed except for a ∼ 20% cell viability reduction in HCVcc-infected cells on the fourth day (Supplemental Fig. 1B ). Together, we were able to establish a dynamic in vitro HCV infection system for further global gene expression profiling.
Subsequently, we examined the hepatocytes miRNA profiles in response to acute HCV infection with the CapitalBio multi-species miRNA microarray (version 4.0; for details, see Materials and methods), on which triplicate probes were included. After the filtration of the signals below the threshold level, 142 miRNAs (including human, non-human and predicted miRNAs) were identified as differentially expressed N2.0-fold in HCVcc-infected samples ( Supplemental Tables 1-4 ). To confirm the microarray hybridization results, RT-qPCR was performed on five randomly selected differentially expressed miRNAs. All the selected miRNAs exhibited expressional patterns that are consistent with the microarray results ( Fig. 1A) , indicating the reliability of the microarray data. Unsupervised clustering ( Fig. 2A ) and scatter (Supplemental Fig. 2 ) analysis of the expression profiles revealed a distinct miRNA signature during acute HCV infection and demonstrated that the majority of the differentially expressed miRNAs were up-regulated in response to virus infection. In summary, 5 miRNAs from day 1 sample, 40 miRNAs from day 2, 63 miRNAs from day 3 and 108 miRNAs from day 4 were differentially expressed by more than two-fold after infection. In addition to day 1, the intersection of the number of co-regulated miRNAs on day 2, 3 and 4 are illustrated in Fig. 2B . The result suggests a continuous and wellregulated miRNA expression pattern through the course of infection. The most significant 22 up-regulated and 20 down-regulated miRNAs in response to HCV exposure are summarized in Table 1 , in which 8 down-regulated and 10 up-regulated miRNAs with the highest fold of change (Figs. 2C and D) were selected for further functional study.
mRNA expression profile of HCV-infected hepatoma cells
A 35K human genome array was used to perform a comprehensive analysis of mRNA expression from HCV or HCVUV-infected Huh7.5.1 cells, on which we also had the miRNA expression profiles. Of 25,100 genes represented on the array, 1247 genes were differentially expressed N2.0-fold (with P-value b0.01, estimated false discovery rate 0.03) during various time courses between infected and control cells . Unlike the miRNA profile, the clustering result demonstrated that the number of up-regulated and down-regulated mRNAs are almost identical between HCV-infected and control cells (Fig. 3A) . Quantitative RT-PCR confirmation on randomly selected differentially expressed mRNAs from microarrays demonstrated a satisfying consistence (Fig. 1B) . The overlaps of coregulated genes on day 2, 3 and 4 showed similar pattern with miRNA profile (Fig. 3B ), and the co-regulated genes among all the 3 days are summarized in Table 2 . These consistently co-regulated genes may play critical roles in infection-induced cytopathogenesis and virus replication itself. Similarly, the top 25 up-and 25 down-regulated genes and their average fold of change during 4 days are showed in Figs. 3C and D. To elucidate the correlation between gene expression pattern and HCV infection-induced biological processes, functional classification of mRNA transcripts by Gene Ontology terms and pathway analysis were performed ( Fig. 4 ). Upon in vitro HCV infection of hepatoma cells, serine protease inhibitor family members (SERPIN-C1, D1, F2), chemokines (CCL20, CXCL5), TGF-β superfamily members (BMP2, GDF15) and various tRNA synthetases (CARS, MARS, WARS etc.) may play central roles for HCV pathogenesis (Fig. 4B ).
Correlation of miR and mRNA expression alteration during HCV infection
To determine whether miRNAs might be modulators of those mRNAs that were differentially expressed, we investigated whether those differentially expressed mRNAs are enriched for predicted targets of each of the human miRNAs in MSigDb database (http:// www.broad.mit.edu/gsea/msigdb/annotate.jsp), in which gene sets contain genes sharing a 3′-UTR miRNA binding motif. To our surprise, targets for the top 10 miRNA or miRNA families account for 17% of the differentially expressed mRNAs in HCV-infected hepatocytes, whereas targets for the top 20 account for 23%, and top 50 for 31% of the differentially expressed mRNAs. Seventeen HCV-affected miRNAs or miRNA families with at lease 4 HCV-affected mRNA targets are listed in Supplementary Table 9 . Although the total number of miRNAs listed in MSigDB is only 222, far less than the miRNA probes represented on the microarray, this preliminary analysis still support the notion that a relatively small number of miRNAs alteration in response to HCV infection could potentially contribute to a large number of changes in mRNA expression. Modulation of specific miRNAs might represent a mechanism that contributes to a major host response to HCV propagation. To this end, we compared the reverse correlation for some of the differentially expressed miRNAs with some of their putative mRNA targets. With the use of either the PicTar or the Targetscan databases, results in Table 3 demonstrated that many differentially expressed miRNAs were inversely correlated with their predicted targets.
Potential effects of differentially expressed miRNAs on HCV entry, replication and propagation
MiRNA could exert regulatory effects on both host and the pathogen. To further investigate whether HCV life cycle is potentially affected by the selected miRNAs, 8 mimics for down-regulated miRNAs and 10 inhibitors for up-regulated miRNAs were synthesized, transfected into cells. Virus entry assay demonstrated that overexpression of hsa-miR-923 or inhibition of hsa-miR-149⁎, 373⁎, 638, 888, 940, 1181, 1234 slightly increased HCVpp entry (∼ 1.4-to 1.6-fold) ( Fig. 5A ). By contrast, none of the miRNA mimics or inhibitors suppressed virus entry. When using genotype 1b replication system, gain of miR-221, 455-3p and loss of miR-887, 940 expression enhanced, but gain of miR-24 and loss of miR-149⁎, 373⁎ expression suppressed HCV RNA abundance ( Fig. 5B ). Finally, HCVcc system was assessed. Results in Fig. 5C demonstrated that transfections of a few miRNA mimics or inhibitors into JFH1-infected Huh7.5.1 cells indeed altered HCV RNA abundance. 
Discussion
Almost 30% of protein-coding genes are predicted to be regulated by miRNAs. Currently, nearly a thousand human miRNAs have been experimentally or in silica cloned, with each of them potentially regulating hundreds of genes by complementary binding to the 3′-UTR of target mRNAs. A number of miRNAs have been shown to play important roles in tumorigenesis, developmental timing and cell death as well as pathogen infection. The liver-specific miR-122 is the first host miRNA that exerts a positive effect on HCV replication in cell culture by binding in the viral 5′-UTR (Jopling et al., 2005) . Recent report further demonstrated that the in vivo steady level of miR-122 correlates with the hepatitis C responsiveness to Interferon therapy (Sarasin-Filipowicz et al., 2009) . Moreover, several interferonmodulated cellular miRNAs were characterized to target HCV genome and show significant antiviral effects in a sequence-specific manner (Pedersen et al., 2007) . Collectively, these findings highlight the important role of host miRNAs in regulating the liver-specific HCV replication, and suggest that miRNAs might be potential targets for hepatitis C therapy. For that reason, the systematic discovery of miRNAs involved in HCV life cycle is urgently needed. Recently, several studies reported the global miRNA modulation in HCV or HCCrelated liver biopsy samples (Peng et al., 2009; Ura et al., 2009; Varnholt et al., 2008) as well as the identification of 188 candidate miRNA expression modification in JFH-1 RNA transfected cells (Ura et al., 2009 ). However, the dynamic and high-throughput miRNA profiling during in vitro HCV acute infection and the potential functional significance of the differentially expressed miRNAs on HCV life cycle are still left unknown.
In this study, based on a comprehensive examination of miRNA expression from JFH-1 HCV-infected and parallel UV-inactivated virus-infected hepatocytes, we identified 142 miRNAs that are differentially expressed, with most (60%) up-regulated in HCVinfected cells. This finding is not similar to prior miRNAs study in HCV-associated HCC (Varnholt et al., 2008) , in which 60% differentially expressed miRNAs were down-regulated. Also, only 4 miRNAs (miR-15a, miR-16, miR-106a and miR-199b) are overlapped between two studies. This may be because miRNA response in acute infection cell model is tightly linked to cell stress or survival and different from that in chronic infection and cancer that are more relevant to differentiation, fibrosis and tumorigenesis. Recent reports documented that host miRNAs (miR-122, miR-199a⁎, miR-196, miR-296, miR-351, miR-431 and miR-448) were able to regulate HCV replication by targeting viral genome (Jopling et al., 2005; Murakami et al., 2009; Pedersen et al., 2007) . Thus, we analyzed whether these miRNAs are differentially expressed in response to virus infection as well. Interestingly, upon HCV acute infection in hepatocytes, miR-122 was down-regulated (2.8-fold), whereas miR-296 (4.9-fold) and miR-351 (15.2-fold) were up-regulated significantly at day 4 postinfection. Such results suggest a host defense response is perhaps mounted to elevate the levels of those antiviral miRNAs and suppress those are supportive to virus infection. This might be also caused by the indirect effects of HCV-induced interferon production.
Because we are unclear how many differentially expressed miRNAs in this study are truly regulators of HCV infection, 18 miRNAs with the highest expression variation and without any previous clue to HCV infection were selected for further functional study, in which 8 miRNAs are down-regulated and 10 up-regulated (Fig. 5) . Several tested miRNAs indeed showed regulatory effects on HCV entry or replication, although results obtained from three experimental systems are hardly consistent. Especially, the lack of concordance of the effects of miRNAs between replicon system and HCVcc system is unexpected (Figs. 5B and C) . On one hand, this may be explained by the characteristics of multiple targets of individual miRNA and these different gene targets exert distinct biological function on HCVcc life cycle. On the other hand, different genotypes, adaptive mutations, with or without an entry step between HCVcc and replicon systems might all potentially make those differences. In general, results from Fig. 5 suggest us that host miRNAs could be efficient therapeutic targets for HCV infection by modulating their expression. Here we take miR-24 for instance, it belongs to miR-23b cluster that targets Smads and suppresses TGF-β/BMP signaling in liver cells (Rogler et al., 2009) . In this study, miR-24 was down-regulated post-HCV infection (Table 1) , and we calculated the fold change of the intracellular HCV RNA abundance is ∼ 2-fold decreased after the transfection of miR-24 mimic into HCVcc-infected Huh7.5.1 cells (Fig. 5B) . These results suggest that host TGF-β signal pathway might be potentially activated upon HCV infection and thereafter a liver fibrosis progress was accelerated. Thus, systematic administration of miR-24 might not only decrease virus replication level but also inhibit hepatic fibrosis.
Several methods and studies have been established to address the regulatory relationships between miRNA and mRNA expression (Hon and Zhang, 2007; Marcucci et al., 2008) . Our simultaneous collecting miRNA and mRNA data from the same samples allowed unveiling correlations of two sets expression profile and their potential (Table 3) , several of them have been implicated in other diseases and biological process. For instance, miRNAs encoded by the miR-15/16 cluster are known to be involved in apoptosis (Cimmino et al., 2005; Guo et al., 2009) , Nodal signaling (Martello et al., 2007) and tumorigenesis (Bonci et al., 2008) . miRNAs encoded by the miR-17/miR-106b cluster are important for epithelial morphogenesis (Carraro et al., 2009) , hepatocellular carcinoma ) and transforming growth factor beta signaling (Petrocca et al., 2008) . miR-29a/b are involved in host-HIV-1 interaction (Nathans et al., 2009 ), p53 pathway (Park et al., 2009 ) and skeletal myogenesis (Wang et al., 2008) . These findings suggest that the expression modification of host miRNAs during acute HCV infection could be related to a number of cellular physiological processes that eventually control the cell fate after combating with virus. In this study, obtaining mRNA expression profile together with miRNA profiling cannot only provide a systematic data for miRNA regulatory network construction but also implicate the more accurate biological significance for HCV acute infection based on our existing knowledge. Recently, Walters and colleagues (2009) reported J6/JFH chimeric HCV infection-induced hepatocytes mRNA profiling using similar strategy, and suggested the potential regulation of cell cycle and apoptosis-related genes. By comparing these two sets data of mRNA profiling, a significant coherence was observed. Among 42 differentially expressed genes identified in this study across 2-4 days post-infection, total 32 (76%) of them were also reported to be regulated in Walters' study (data not shown). The consistent results from two independent experiments suggest the conserved HCV infection-stimulated cellular responses and cytopathic mechanisms existed. After carefully analyzing those differentially expressed mRNAs, we are interested in a number of genes that may deserve for further characterization. Among them, the expression of several circulating factors, including lipoprotein metabolism components (APOA1, APOC1, APOC2, APOC3, APOH, APOM), bone morphogenetic protein 2 (BMP2), erythropoietin (EPO), transforming growth factor, beta-induced (TGFBI) and growth and differentiation factor 15 (GDF15), was significantly regulated, which suggests that these factors might be prognostic biomarkers and dysregulate host homeostasis after HCV infection. The notable suppression of tight junction protein Claudin-14 (CLDN14) after infection implicated the potential role of CLDN14 on HCV entry (Evans et al., 2007; Yang et al., 2008b) . The mechanisms of chronic hepatitis C-related hepatocellular carcinoma are still under debating between pathogen and immunological stress-induced tumorigenesis. Interestingly, our mRNA profiling results demonstrated that among differentially expressed genes, all 7 oncogenes (MYC, DEK, ELF3, JAK1, KLF6, KRAS and PTPN11) were up-regulated, but the only tumor suppressor fumarate hydratase (FH) was down-regulated. This result provided evidence that virus propagation stimulated liver gene modification might exert important function on HCV-induced hepatocarcinogenesis.
In summary, these findings suggest that host miRNAs are an important category of targets and may play a role in regulating the gene expression response to HCV infection in liver cells. miRNA and mRNA profiles obtained from these cells might therefore serve as biomarkers for HCV-related liver diseases and help elucidate the regulatory mechanisms that mediate the host response to HCV exposure and other pathogens.
Materials and methods
Cells, HCVcc production and infection
The human hepatoma cell line Huh7.5.1 was provided by Dr. Francis V. Chisari (The Scripps Research Institute, La Jolla, CA). The HCV genotype 1b-replicon-containing cell line (2 − 3 + ) was a generous gift from Dr. Stanley Lemon (University of Texas Medical Branch, Galveston, TX). HEK293T cells were obtained from ATCC. All cell lines were maintained in DMEM (Gibco/Invitrogen, Carlsbad, CA) supplemented with 1% Penicillin and streptomycin (Gibco), 1% NEAA (Gibco) and 10% fetal bovine serum (Gibco) in a 37°C 5% CO 2 atmosphere. G418 (500 μg/ml) was routinely added into the 2 -3 + cells to maintain the viral RNA replication. The production of HCVcc (JFH-1) was performed as described . Briefly, JFH-1 genome RNA was in vitro transcribed with RiboMAX Large Scale RNA Production Systems (Promega, Madison, WI), purified with MEGAclear Kit (Ambion) and transfected into Naïve Huh7.5.1 cells with TransMessenger Transfection Reagent (Qiagen). The transfected cells were cultured and routinely expanded for 10 days and the collected virus containing supernatants were pooled and further used to inoculate naïve Huh7.5.1 cells. This supernatant collection/naïve cells inoculation process was repeated at lease for 5 cycles with 7 days each cycle to produce large volume HCVcc stock with relatively high viral titer. For infections, HCVcc (MOI = 1.0) and same amount of parallel ultra-violet inactivated virus (HCVUV) were used to inoculate 5 × 10 6 naïve Huh7.5.1 cells and incubate overnight. Inactivation of HCV by UV was achieved by exposing virus-containing supernatant in Petri dish (0.5 cm depth) to 254 nm UV source at 1.8 Jm − 2 per second for 30 min. The infected cells were washed and maintained in fresh medium for 1, 2, 3 and 4 days, respectively, prior to microarray analysis.
Microarrays and bioinformatics
Total RNA was isolated from HCV or HCVUV-infected Huh7.5.1 cells with Trizol reagent (Invitrogen). miRNA and mRNA hybridization was performed by CapitalBio Corporation (Beijing, China) with 
Quantitative real-time RT-PCR (RT-qPCR)
For selected mRNA RT-qPCR, total RNA from the same samples used in microarray analysis was tested using the ABI Prism 7500 System. Real-time quantification was employed using SYBR Green PCR Master Mix (ABI). PCR primers were designed with AB PRISM Primer Express 2.0 software. Results are shown as fold change. For miRNA RT-qPCR, experiments were carried out with the miRNA Reverse Transcription kit (Applied Biosystems) and miRNA Taqman Expression Assays (Applied Biosystems) according to manufacture's instruction. Quantification of HCV genomic RNA was performed with real-time RT-PCR as described in reference (Komurian-Pradel et al., 2001) . Immunostaining and confocal microscope HCV or HCVUV-infected Huh7.5.1 cells were fixed in 2% paraformaldehyde (dissolved in PBS, pH7.2) for 10 min at room temperature (RT). Cells were then permeabilized with 0.2% (v/v) Triton X-100 in PBS three times (PBST; 10 min each time, RT) and incubated in PBS (overnight at 4 ο C) with 1:200 diluted antibody against HCV Core protein (Affinity BioReagents, Golden, CO). Samples were washed in PBS and sequentially incubated with FITC-conjugated secondary antibody (Santa Cruz) diluted in PBS (1:100). Samples were finally washed three times in PBS and mounted on a slide. Nucleus was visualized with DAPI staining during the second wash. Images were captured on a Leica TCS SP5 confocal microscope.
Cytotoxicity assays
Naïve Huh7.5.1 cells were plated in quadruplicate in 96-well plates at a density of 1 × 10 4 cells/well 1 day before infection, followed with HCV or HCVUV infection at MOI = 1.0 for various days. Cell viability and cytotoxicity were examined with MTT assay kit (Promega) according to manufacture's instruction.
MiRNA transfection
Selected miRNA mimics and inhibitors were synthesized by Qiagen. MiRNA mimics are chemically synthesized double stranded miRNAs which mimic naturally occurring miRNAs after transfection into the cell. miRNA inhibitors are single-stranded, modified RNAs which, after transfection, specifically inhibit miRNA function. These miRNA mimics and inhibitors were transfected into naïve Huh7.5.1 cells at a final concentration of 50 nM with HiPerFect Transfection Reagent according to Qiagen recommended protocol. Twenty-four hours post-transfection, the cells were spin infected with lentivirus particles pseudotyped with HCV E1 and E2 glycoproteins (HCVpp) to evaluate the effects of miRNAs on HCV entry. For 2 − 3 + replicon cells, total RNA was isolated 24 h post-transfection with miRNA mimics and inhibitors for HCV replication quantification by real-time RT-PCR. For the assessment of miRNA effects on HCVcc infection, naïve Huh7.5.1 cells were infected with HCVcc at low MOI (=0.1) on the first day and followed with miRNA mimics and inhibitors transfection on the second day. HCV genome quantification by qRT-PCR was performed on the fourth day post-infection. All experiments were carried out at triplicates. To confirm the efficiency of transfection, the same amount of Cy3-labelled negative control (Ambion) was also transfected and followed by fluorescent microscope observation.
Production of HCVpp and the entry assay
HCVpp packaging was performed as described elsewhere (Yang et al., 2008b) . Briefly, HEK293T cells were seeded 1 day before transfection at 2.5 × 10 6 cells in a 10-cm plate. Cells were transfected using TransMax Transfection Reagent (Giantagen, Beijing, China). The transfecting DNA mixture (1 ml) was composed of 15 μg of pNL-4.3-Luc-E − R − , either 15 μg of phCMV-HCV E1E2 (genotype 1a) or 3 μg of pHEF-VSV-G. Culture supernatants containing HCVpp or VSVpp (lentivirus particles pseudotyped with VSV-G glycoprotein) were collected at 48, 60 and 72 h post-transfection and filtered through 0.22-μm syringe filter. For virus entry assay, Huh7.5.1 cells were seeded in a 24-well plate at the density of 1 × 10 5 /well on the day before transduction. On the following day, the cells will be supplemented with 500 μl of HCVpp or VSVpp containing supernatants in the presence of 8 μg/ml of polybrene and 5 μl of 2 M HEPES (pH 7.55) and spin infected for 1.5 h in a table-top centrifuge (2500 rpm, 30°C) and followed by another 1.5 h incubation in a CO 2 cell incubator. Cells were lysed at 48 h post-spin infection and assayed with Luciferase Assay System (Promega) in a Modulus Microplate Luminometer (Turner BioSystems). All experiments were performed in triplicates. To obtain the specific HCV envelope proteins (E1/E2) mediated cell entry, normalization of HCV entry assay was carried out by dividing of HCVpp relative luciferase units (RLU) by relative VSVpp variation folds.
